Conference Speakers

Mark Adams has had three very different careers in his life. The first was in law enforcement, where he spent 21 years as a member of the Philadelphia Police Dept, retiring as a Captain. His second career was at Merck & Co., where he spent 14 years in the Compliance Dept., retiring as an Executive Director. Most recently, he served as the VP of Audits at G&M Health, LLC. He has a Master’s Degree from St. Joseph’s University in Public Safety. In his 19-year tenure with the Alliance, he has been President, VP, Treasurer, and Operations Director. He feels the members all share a sense of purpose, that of compliance. He brings value to the group through his varied life experiences and hopes that this experience helps solve compliance-related issues for members. Mark has been married for 42 years, with 2 grown children, a grandson, and a granddaughter. In his spare time, he enjoys the Jersey Shore and daydreaming of life on the Senior PGA Tour.

Lisa A. Butler is the Director of State Licensing, DEA/PDMA Compliance within the Ethics, Risk & Compliance, CIA Operations area of Novartis Pharmaceuticals Corporation. She has held various roles within the pharmaceutical industry for the last 34 years and has worked within her current area of responsibility for the last 24. Lisa’s areas of expertise include DEA Controlled Substance compliance, PDMA Sample Compliance and State and Federal commercial distribution licensing for pharmaceutical products. She holds a B.S. in Business Administration from Centenary College in NJ. Lisa has been an Alliance Board Member since 2009 and is the current Sharing Alliance President. Lisa has been married to her best friend for 30+ years and has two daughters, two sons and three amazing grandchildren.

Eric brings over 26 years of pharmaceutical experience in field strategy, analytics, operations and finance. Has worked in a number of positions of increased responsibility supporting multiple primary care and specialty brands through launch and mature life cycles. Instrumental in providing valuable insights and analysis to multiple business units along with contributing to many key commercial projects. Demonstrates exceptional technical knowledge, strategy, simplification, effectiveness, collaboration, communication and leadership across multiple functional areas to support pharma business growth.

Steve is a 35+ year employee with Eli Lilly and Company and has served as Vice-President – Chief Compliance Officer, North America since August 2021. Prior to his current role, he served as Area Vice-President of Sales across multiple therapeutic areas responsible for Lilly’s Neuroscience and Cardiovascular portfolio of products. Steve is based in Indianapolis, Indiana.

Crissy Corbin holds the position of Account Manager, Sample Accountability, US Regulatory Compliance (formerly BuzzeoPDMA) with IQVIA. Crissy has been with the organization since 2019 as is responsible partnering with clients to enhance and streamline sample accountability and sample operations programs with a focus on service delivery, regulatory compliance and operational excellence.

Prior to her time in the Life Sciences sector, Crissy lead operational support teams in both the Data Management and Financial Services fields.

Crissy earned a BBA in Marketing from James Madison University.

Alison Crawley is the Global Sustainability Manager for ThermoSafe. She works collaboratively across businesses to implement strategies to minimize the environmental impact across the supply chain, while working closely with customers to support progression of sustainability initiatives. Alison has more than 7 years of experience in sustainability, with a specialty in life cycle assessment (LCA). She is a strong advocate for best practices and data-driven decisions empowering companies with effective ways to reduce environmental impact, socialize their sustainability journey and achieve goals. Alison earned her B.S. in Environmental Engineering from Ohio State University.

Jon Dellaquila is the Executive Director and Compliance Lead for the U.S. Oncology franchise at Incyte, where he is responsible for implementing the company’s compliance program to foster a culture of integrity, transparency, and accountability. In this role, Jon collaborates with functional leadership to achieve business objectives by identifying and mitigating potential risks while ensuring activities comply with internal policies. Prior to joining Incyte, Jon worked at Amneal Pharmaceuticals, Shire, and Johnson and Johnson in various compliance roles with increasing responsibility.

Don has over 30 years experience in the pharmaceutical industry, including being past President of the Sharing Alliance. Most recently Don was Associate Director of Sample Operations, Cold Chain Hand Sampling at Sanofi. Prior to that Don was Manager of Sample Accountability at Bayer and Berlex Labs for over 20 years. Don’s background includes high volume distribution operations and warehouse management in pharma and various other industries as well as small business owner of a startup contract packaging company for 5+ years. Don has a BS degree in Materials and Logistics Management from Michigan State University. Don resides in northern New Jersey with his wife of 49 years on their “mini” 7 acre farm where they enjoy working in their Apiary and selling their honey under the label “Bee My Honey Farms”.

Stacy Diefenbach has been with Bristol Myers Squibb since 2005. She started her BMS career in Medical Information but has held various roles in the Samples Management space since 2008, currently as Senior Manager, Samples Management. She enjoys providing support and guidance to the sales reps to ensure they stay compliant with their sampling activities, and is always looking for ways to improve efficiencies both in the home office and in the field.

Sarah K. diFrancesca is the Executive Director of Compliance for the Dermatology Business Unit at Incyte, where she is responsible for identifying and prioritizing areas of risk and supporting ethical and risk-based decision-making throughout the business unit. This includes partnering with senior management, overseeing continuous improvement of the company’s compliance program, and informing compliance monitoring activities. Prior to joining Incyte, Sarah was a partner at Cooley LLP and Dinsmore & Shohl, where she counseled life sciences clients on regulatory compliance and government fraud investigations.

With over 18 years of experience in the cold chain packaging industry, Chris has honed his expertise in last mile shipping and direct-to-practitioner programs. His extensive client experience spans large pharmaceutical companies, clinical packaging, wholesale, and sampling programs. Chris holds a Master of Science in Business Administration with a concentration in Finance from Kutztown University and an MBA from Moravian University. With a strong educational foundation, Chris brings a wealth of knowledge and expertise to his professional endeavors.

Married to his wife Nicole for over 17 years, Chris exemplifies dedication both professionally and personally. Based out of Eastern Pennsylvania’s Lehigh Valley, Chris spends most of his free time with his two boys, aged 12 and 11, actively participating in their sporting activities, including baseball, basketball, and soccer, both as a coach and a supportive spectator.

Tracey has over 25 years of experience in managing compliance programs for the pharmaceutical and medical device industries. With a strong focus on business ethics and integrity, Tracey is skilled at balancing ethics and compliance adherence with business realities. She is well versed in the healthcare compliance landscape and has been focusing on Data Privacy and Protection programs in recent years, while still supporting the commercial organization’s compliance strategies. Tracey believes that ethical decision-making serves as the foundation for achieving sustainable commercial success and actively works to promote and support this approach.

Teresa is the Associate Director of Sales Operations for Otsuka America Pharmaceutical, Inc. Teresa has been in the Pharmaceutical Industry for over 25 years working in various Functional areas such as Finance, Field Sales Force and Sales Operations. In her current role, Teresa oversees all Otsuka Sampling programs (Direct to Practitioner and Sales Rep Hand Carry). Teresa has a bachelor’s degree in accounting from Rider University and a master’s degree in Fraud and Forensic Accounting from Rider University.

Judy is the Director of Compliance Services at QPharma, Inc. where her responsibilities include ensuring compliance concerns and requirements are addressed in the management of client’s commercial programs. Judy also serves as QPharma’s practice lead for spend and sample transparency reporting services. She assists clients in developing Commercial Corporate Compliance program policies, procedures and codes of conduct and conducting audits of the related programs. Judy specializes in a risk-based approach to services and programs and is considered a Subject Matter Expert in federal and state compliance, sample compliance and transparency reporting regulations. Judy’s experience includes serving as a featured speaker, panelist and moderator at numerous industry conference presentations, webinars relating to government regulations and requirements. She has presented Federal and State Compliance and Reporting Workshops to key stakeholders in the industry and has had several industry articles published throughout her career. Judy lives in New Hampshire with her husband, Mike Simmons.

Chuck Gallagher is a business ethics expert, consultant, keynote speaker, and author who inspires positive behavior with an enlightening discussion on choices, consequences, and ethical behavior. He shares his personal experience to highlight the harmful effects of unethical decisions and the powerful impact of doing the right thing. Chuck’s inspiring message has helped countless companies minimize their exposure to risks associated with unethical behaviors.

In addition to his business ethics acumen, Chuck has extensive knowledge of artificial intelligence (AI). By offering his expertise on the subject, he’s helped audiences around the country grasp AI technology and discover how it can drive efficiency in their daily operations.

John A. Gilbert Jr. is the Director at Hyman, Phelps & McNamara, P.C., drawing on decades of experience to advise clients across the supply chain on legal and regulatory issues related to controlled substances, prescription drugs, and precursor chemicals.
He has extensive knowledge of international, federal, and state laws and regulations governing the drug supply chain and has represented numerous clients in cases involving violations of these laws. Mr. Gilbert also has extensive expertise in compliance matters and frequently conducts compliance-related investigations and inspections.

Prior to joining Hyman, Phelps & McNamara, P.C., Mr. Gilbert served as an attorney in the DEA’s Office of Chief Counsel, Diversion/Regulatory Section and worked as law clerk for the DEA’s Chief Administrative Law Judge. He holds a J.D. from the Columbus School of Law at the Catholic University of America and a B.A. in Political Science from Westfield State College.

To Come.

Ms. Gunner currently serves as Associate General Counsel and Director of Compliance at CMP Pharma, where she acts as the sole legal counsel and compliance resource for the organization. In this role, she provides strategic legal guidance and oversees all aspects of commercial compliance. Prior to joining CMP, Ms. Gunner successfully led the development and implementation of robust compliance and privacy programs across the pharmaceutical, telehealth, and medical device sectors, bringing a practical and business-minded approach to navigating complex regulatory and compliance environments.

Brad has been working in the Pharmaceutical Industry going on 30 years. He was employed with Cencora, (formerly AmerisourceBergen), for 20 years, which is currently ranked number 10 as a fortune 500 company. He had Compliance oversight at a division level as the Senior Regulatory Compliance Manager/Compliance Officer for the administrative and distribution/pharmacy side of the business covering oncology drugs, OTC, Controlled Substances and Med Surg also serving as the HIPAA Privacy/Security Officer. He is currently employed with Kowa Pharmaceuticals America, Inc. (KPA) located in Montgomery, Alabama being the home office for the United States. His responsibilities with KPA include oversight in many facets of Regulatory and Healthcare Compliance in areas such as facility, Rep., and HCP licensing, state/federal aggregate spend/drug price transparency, compliance reporting, compliance training, audits covering (e.g., SBOP, NABP, DEA, FDA, DSCSA, CMS and PDMA). The parent company for KPA is Kowa Company, Ltd. (KCL) residing in Japan. He has worked for a “Big 3 Drug Wholesaler”, a Specialty Pharmacy, and now a Manufacturer. His core areas of experience throughout the Supply Chain include Regulatory and Healthcare Compliance, Business Operations and Drug Distribution/Logistics and Fleet. He graduated from Troy University with a Master’s Degree in Healthcare Management (concentration Leadership/Organizational Effectiveness), a Master’s Degree in Human Resource Management, and a Bachelor’s of Science in Business Administration. In his free time, he enjoys being in the outdoors with his son, Collier, and helping coach his baseball and football teams.

Jennifer is the Associate Director in Sales Operations at Gilead Sciences. Her experience includes over 10 years in the biotech pharmacology and healthcare industries. Her previous work experience includes being Neuroscience/Nuerosurgery Nurse, and Human Resources Director in the hospitality industry.

Her current role includes leading the Drug Sample and Compliance Programs, where she manages sample accountability and the direct to practitioner programs. Over the years, she has launched several sample programs, supported the implementation of PDMA guided policies, conducted sample field training, and worked with key stakeholders to uphold all compliance requirements. Her additional role in Sales Operations includes Field Sales Enablement where she oversees Field Credentialing, Jurisdiction State Licensing, and Exhibits just to name a few.

Jennifer is a native of San Francisco Bay Area where she received her B.S. in Organizational Behavior with a concentration in Human Resources Management from the University of San Francisco, and attended US University in San Diego, California and attained her RN License. Jennifer is married and is a “baseball mom” who will cheer on her son Sam while he plays D1 Baseball in college. Other time well spent is spoiling and walking the adorable Golden Doodle Jax.

Marc Lavin has worked at Pfizer for 30 years. His entire tenure at the company has been devoted to supporting regulated environments (GxP, PDMA, SOX). Marc is currently the Director of HCP/Patient Compliance and Audit, responsible for oversight of compliance for samples, savings cards, meetings, and promotional materials in North America. Marc has vast experience in managing large-scale, cross-functional projects in many different functions, including information technology. He was a key player in the development and implementation of Pfizer’s global samples policy which is in place in over 60 markets.

With over 25 years in the industry, Ruby is a seasoned professional specializing in sales enablement. Throughout her career, she has worked closely with sales professionals, providing them with the tools, training and strategies needed to succeed in their roles. Her expertise lies in optimizing sales processes, enhancing team performance, and driving revenue growth through effective sales enablement strategies.

Aaron Lehikoinen, Associate Director – Global Sample Operations, Eli Lilly & Co. has over 19 years of successful experience working in the pharmaceutical industry with positions in Sales, Ethics and Compliance, Lilly Patient Services, Sample Accountability, and previous Sharing Alliance Industry Board Member.

Aaron graduated from Brigham Young University with Phi Alpha Theta Honors and remains connected by serving as the BYU Alumni Chair for the Indianapolis Chapter. He is married and has 5 lively children. In his “free time”, Aaron enjoys serving at church, coaching sports, traveling with his family, running, and cheering for BYU sports!

As co-founder and Managing Director of G&M Health, Bob provides executive leadership for the company based on his 20 plus years of pharmaceutical regulatory and compliance experience. Prior to founding G&M, Bob was Vice President & Managing Director of PRS Franklin, an inVentiv Health Company, heading the Compliance Management and Commercial Services divisions with responsibility for over 125 employees and 35 healthcare industry clients. Before joining inVentiv Health, Mr. Melillo was a co-founder and Managing Director of Pharmaceutical Resource Solutions, LLC (PRS), where he created several compliance software applications, and was author of The Melillo Review, an industry compliance newsletter.

In private practice, Bob served as General Counsel and Regulatory Advisor for several healthcare companies, including PharmFlex Inc. and Snyder Healthcare Sales, providing pharmaceutical regulatory and compliance guidance for their commercial and promotional activities. He holds a Juris Doctor from Albany Law School, and a Bachelor of Science degree from Trinity College in Connecticut.

To Come.

Faiza has over two decades of experience in regulatory and compliance and pharmaceutical operations, with expertise in DEA controlled substance regulations and inspection readiness.

She is currently the Director of Regulatory and Compliance at IBSA Pharma Inc. Faiza is primarily responsible for the establishment and monitoring of standard operating procedures and compliance policies, employee training and State Transparency reporting compliance. She’s also overseeing the company’s commercial state licenses and ensuring compliance with state Boards of Pharmacy regulations for distribution of pharmaceutical product.

Bill Samuelson has been a sales and account management professional in the pharmaceutical and biotechnology service provision space for 20 years. He has supported drug product launches focusing on sampling programs in both hand carry disbursement and direct to practitioner distribution protocols. Launches he has supported run the gamut of large to small patient populations, controlled products, REMs, and cold chain. Bill has witnessed and can demonstrate the value that sampling adds to a product launch. He has encountered and managed challenges these programs face at inception and throughout the lifecycle of a product, including post loss of exclusivity.

MaryLou Schoonover currently serves as the Customer Due Diligence and State Licensing Senior Manager of the DEA Compliance Team for Endo USA, Inc. She is responsible for the licensing of all the Endo facilities as well as the DEA Suspicious Order Monitoring and Customer Due Diligence program. Mary-Lou has over 25 years of combined experience between Prescription Drug Marketing Act (PDMA) and DEA compliance in the pharmaceutical industry. She has previously worked for MedPro Systems, Allergan (formerly Actavis), Reckitt Benckiser, and the United States Pharmacopeia (USP). Considered a subject matter expert in State Licensing, PDMA and DEA Compliance, MaryLou attributes her wealth of knowledge and professional success to the individuals she has worked with throughout her career. She has a Bachelor of Science in Business Administration and Management from Centenary University and is a graduate of the National Academy of Paralegal Studies. MaryLou is a Certified Corporate Paralegal. She has served as an industry volunteer for various organizations and is a frequent presenter at industry conferences. She is a member of or affiliated with the New Jersey Pharmacy Industry Group (NJPIG), National Association of State Controlled Substance Authorities (NASCSA), National Association of Drug Diversion Investigators (NADDI) and IQVIA. MaryLou was the recipient of the 2021 President’s Award from NASCSA and, the 2021 Inaugural Endo Living Our Values Award for Integrity and Quality. In her spare time, MaryLou volunteers with organizations committed to safe and healthy, drug-free families in NJ.

Deb Segura is the Executive Director of the Sharing Alliance and has over 30 years of experience in the pharmaceutical industry. She has dedicated herself to providing valuable compliance information to Alliance members and industry. She is a founding member of the Sharing Alliance, a not-for-profit organization established in 1989 with a mission to improve the pharmaceutical industry’s understanding of the Prescription Drug Marketing Act (PDMA) and related sample compliance regulations. Prior to taking the position of Executive Director, Deb’s career included various management positions at Kos Pharmaceutical (now Abbott), Novo Nordisk, and Bristol Myers Squibb. Her primary focus was sample compliance, education and training, and sample investigations. She is the proud mother of three wonderful children and grandmother to five. She and her husband reside in York, SC.

Debbie Tay has over twenty years of broad sales operations experience including Sample Compliance, Sales Force Automation, Field Reporting, Fleet, HR/Benefits, Recruiting and Incentive Compensation. She is currently the Senior Manager Master Data Operations. In her role as a results producing manager and team member who consistently demonstrates strong leadership in improving systems and processes to meet the business acumen. Her in depth experience of more than 15 years of innovative successful sales operations and HR productivity development of intuitive compliant processes. She has led advances in technology and field enablement for a variety of Specialty Pharmaceutical, Hospital and Managed Markets teams. In addition to incentive compensation design and KPI scorecards to motivate sales teams to fulfill business strategy plans. Debbie holds an MBA from University of Phoenix majoring in Business Administration and is a current Sharing Conference Board Member.

Jessica Youngs is the Director of Business Relations at QPharma, where she spearheads initiatives to enhance sample management programs through innovative methodologies. With extensive experience in the pharmaceutical industry, Jessica is dedicated to optimizing business processes and fostering strong client relationships. She holds a pivotal role in driving innovation and efficiency at QPharma.